Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:ACOR’

Paul Marshall Marshall Wace

Here’s What Hedge Funds Think About Acorda Therapeutics Inc (ACOR)

“The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among......(read more)
Philippe Jabre

Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?

Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter. NASDAQ and Russell 2000......(read more)
Covalis Capital's Returns, AUM and Holdings

Hedge Fund and Insider Trading News: Israel Englander, Omega Advisors, Jabre Capital, Red Lion Hotels Co. (RLH), Amkor Technology, Inc. (AMKR), and More

Omega, Jabre Capital Among Hedge Fund Casualties in Dismal 2018 (Bloomberg) (Bloomberg) — It has been yet another year to forget in the world of......(read more)
Insider Trading

Hedge Fund and Insider Trading News: David Tepper, Soros Fund Management, Lixte Biotechnology Holdings Inc (LIXT), Acorda Therapeutics Inc (ACOR), Achaogen Inc (AKAO), and More

David Tepper: Fed Is Done Supporting Stock Prices, So Cash Is ‘Not So Bad’ As An Investment Now (CNBC) Hedge fund titan David Tepper said Thursday......(read more)
MILLENNIUM MANAGEMENT

Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?

The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or......(read more)
insider trading insider buys

Hedge Fund and Insider Trading News: John Paulson, Ray Dalio, International Flavors & Fragrances Inc (IFF), KAR Auction Services Inc (KAR), Second Sight Medical Products Inc (EYES), and More

Paulson & Co to Ask Detour Gold for Special Meeting for Board Overhaul (Reuters) (Reuters) – Activist investor John Paulson’s hedge fund on......(read more)
Sergey Nivens/Shutterstock.com

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

Acorda Therapeutics Inc (NASDAQ:ACOR): Matt Sirovich And Jeremy Mindich’s Scopia Capital filed an amended 13D. You can check out Scopia Capital&#......(read more)
Insider Trading Wall Street Trader Panic

Hedge Fund and Insider Trading News: Och-Ziff Capital Management, Jana Partners, Intrexon Corp (XON), Legacy Reserves LP (LGCY), and More

Och-Ziff Capital Names Robert Shafir as CEO (Reuters) (Reuters) – Och-Ziff Capital Management on Tuesday named Robert Shafir as its new chief executive......(read more)
Insider Trading, NYSE, Markets, Stock Trader On The Phone

Hedge Fund and Insider Trading News: Elliot Management, Brevan Howard, Acorda Therapeutics Inc (ACOR), Cognizant Technology Solutions Corp (CTSH), and More

Singer’s Elliott Management Buys Sky Stake Ahead of Vote (Bloomberg) Elliott Management Corp., the hedge fund founded by billionaire Paul Singer......(read more)
stock, market, business, app, shares, share, news, global, man, phone, big, graph, chart, using, screen, fast, motion, concept, internet, up, tablet, touching, technology,

Market Movers Today: Nike Inc (NKE), Forward Industries, Inc. (FORD), International Business Machines Corp (IBM), and More

Nike Inc (NYSE:NKE) (TheStreet) Shares of Nike (NYSE:NKE) rose over 3% Friday morning following an upgrade by Wedbush to Outperform (from Neutral) with......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

Acorda Therapeutics Inc (NASDAQ:ACOR): Matt Sirovich and Jeremy Mindich’s Scopia Capital filed an amended 13D. You can check out Scopia Capital&#......(read more)
Easiest Md/PhD Programs to Get Into

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Pressmaster/Shutterstock.com

13G Filing: Partner Fund Management and Acorda Therapeutics Inc (ACOR)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Here’s What Is Happening In Financial Markets Today?

1. US Stock Market: “Wall Street stocks on Monday were aiming to start the second quarter with tepid gains. Investors were set to take cues from a handful......(read more)
stocks, analysis, market, numbers, business, ticket, trade, money, price

What Is Going On In The Financial Markets Today?

1. US Stock Market: “U.S. stocks were slightly lower on Friday, dragged down by technology stocks as investors locked in gains of what is likely to......(read more)
Easiest Md/PhD Programs to Get Into

Generic Competitors A Looming Threat For Acorda Therapeutics Inc (ACOR)

In order to ensure an extension of Ampyra’s protection to 2026, Acorda Therapeutics Inc (NASDAQ:ACOR) must fight off competition from competitors such......(read more)
Copyright: lenetstan / 123RF Stock Photo

Can Acorda Therapeutics Inc (ACOR) Give Eli Lilly And Co (LLY) A Run For Its Money In Migraine Drug Market?

Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE......(read more)
trade, forex, investment, gain, stock, phone, network, view, report, money, smart, background, broker, market, laptop, table, economy, display, loss, business, urban,

Acorda Therapeutics Inc (ACOR) Continues To Fall From Favor With Top Investors

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Biotech Movers And Shakers: Mast Therapeutics, Inc. (MSTX) And Acorda Therapeutics Inc (ACOR)

To find a winner in the biotech space this week, all you’d need to do is throw a dart at a basket of micro-caps. Sub $100 mm juniors have – pretty......(read more)
drilling, oil, sunset, oilfield, tool, donkey, power, business, pipeline, income, orange, black, technology, equipment, energy, gas, pumping unit, mineral, barrel, platform, oil

Skypeople Fruit Juice Inc. (SPU), Lands’ End Inc. (LE) & Others: Why These Losers Are Dragging Down the Market

The markets continue to trade down in anticipation of the upcoming OPEC meeting. Another important factor affecting the markets today is the upcoming......(read more)
Biotech Stocks 7

Why Does The Smart Money Like Acorda Therapeutics?

Acorda Therapeutics Inc (NASDAQ:ACOR) is a $1.11 billion biotechnology company that develops and commercializes novel therapies for neurological disorders......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (ADMS) And Acorda Therapeutics Inc (ACOR)

We just got a couple of updates in the Parkinson’s space, and both have the potential to serve up some volatility in the market capitalisations of the......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Should You Buy Acorda Therapeutics Inc (ACOR)?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
John Scully - SPO Advisory Corp

These Oil and Biotech Stocks Are in the Crosshairs of Elite Investors

While many hedge funds are still preparing their third quarter filings with the SEC, providing the main ingredients for our delectable small-cap investment......(read more)
Kyle Bass

Kyle Bass’ War Against Pharmaceutical Companies Goes On While The Masses Overlook China’s Real Problem

Those who seek to profit from shorting strategies should keep a close eye on Kyle Bass’ war against the pharmaceutical industry. The founder of Hayman......(read more)
Most Affordable Medical Schools in Europe

Acorda Therapeutics Inc (ACOR)’s Shares Jump After Dismissal Of Patent Challenge From Hedge Fund Manager Kyle Bass

The shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are trading 13.16% higher today after the dismissal of a patent challenge against the company. Kyle......(read more)
Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......(read more)
Acorda Therapeutics Inc (NASDAQ:ACOR)

Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It

To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds......(read more)
Sarepta Therapeutics Inc

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It

Who’s crazy about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)? If you were to ask many market players, hedge funds are seen as useless, outdated......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks

Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish......(read more)
Nektar Therapeutics (NASDAQ:NKTR)

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world......(read more)
Acorda Therapeutics Inc (NASDAQ:ACOR)

Is Acorda Therapeutics Inc (ACOR) Going to Burn These Hedge Funds?

Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of March. ACOR has experienced a decrease in hedge fund sentiment......(read more)

This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds’ portfolio at the end of March. SRPT shareholders have witnessed an increase in enthusiasm......(read more)
Idenix Pharmaceuticals Inc (NASDAQ:IDIX)

Idenix Pharmaceuticals Inc (IDIX), Alnylam Pharmaceuticals, Inc. (ALNY) & 3 Small Biotechs Top Hedge Funds Are Investing In

Small biotech companies have great investment potential if you can identify them properly. A small biotech with a differentiated treatment approach and......(read more)

Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech – Part Two

As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector. A PDUFA decision, as well as three FDA panel reviews/findings......(read more)

Biogen Idec Inc. (BIIB): What Goes up Must Come Down

Biogen Idec Inc. (NASDAQ:BIIB) is one of those rare companies in the healthcare sector whose stock has relentlessly outperformed the broader market continuously......(read more)
Theravance Inc (NASDAQ:THRX)

Biopharma News: Theravance Inc (THRX), VIVUS, Inc. (VVUS), Amgen, Inc. (AMGN)

Editor’s Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc. (NASDAQ:AMGN), Acorda Therapeutics Inc (NASDAQ......(read more)
Steven Cohen, Point72 Asset Management

Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?

Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of the fourth quarter of 2012. ACOR investors should pay attention......(read more)